Latest Press Releases

1000 Miglia 2025, Vesco-Salvinelli six times champions in a 1929 Alfa Romeo 6c 1750 Ss

BRESCIA, Italy, June 23, 2025 (GLOBE NEWSWIRE) -- After 5 racing days , 1900 kilometres and over 400 classic cars in movement, today the forty-third re-enactment of the 1000 Miglia ended in Brescia . A special edition, bringing back to ...

Why Health Insurance Is a Must-Have in Today's World

In an uncertain world in which it seems uncertainty is forever knocking at the front door, never has our health been more important to safeguard. Contemporary way of living, high medical expenses and unexpected ailments have ensured that ...

REZOLVE-AD Phase 2b Study of Rezpegaldesleukin Meets Primary and Key Secondary Endpoints in Patients with Moderate-to-Severe Atopic Dermatitis

PR Newswire SAN FRANCISCO, June 24, 2025 Achieved statistical significance on primary endpoint at week 16 for mean percent change in EASI score from baseline for all rezpegaldesleukin arms versus placebo Achieved statistical significance ...

School Children Jump to Raise $98K for American Heart Association

PR Newswire GRAND RAPIDS, Mich., June 24, 2025 Families learn life-saving techniques while raising funds for children with special heart needs GRAND RAPIDS, Mich., June 24, 2025 /PRNewswire/ -- Students at 25 National Heritage Academies ...

Colgate's Oral Health Movement - 4.5 Million Screened, Interesting Insights Uncovered, Drives Dental Visits Across India

PR Newswire NEW DELHI, June 24, 2025 Colgate's Oral Health Movement reveals India's Oral Health Score as 2.6 out of 5, signalling the need for prioritization of Oral Care in the country NEW DELHI, June 24, 2025 /PRNewswire/ -- ...

Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis

PR Newswire NEW YORK, June 24, 2025 – At Week 144, 92.3% of Patients Remained Free of 12-Week Confirmed Disability Worsening (CDW) With 92.7% Remaining Free of 24-Week CDW – – Vidofludimus Calcium Continues to Demonstrate Favorable ...

Nuvalent Announces Positive Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC

PR Newswire CAMBRIDGE, Mass., June 24, 2025 CAMBRIDGE, Mass., June 24, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven ...

Sterotherapeutics Announces First Patient Dosed in Phase 2 Clinical Trial Evaluating ST-002 for Cushing's Syndrome

PR Newswire DOYLESTOWN, Pa., June 24, 2025 DOYLESTOWN, Pa., June 24, 2025 /PRNewswire/ -- Sterotherapeutics LLC, a clinical-stage biopharmaceutical company focused on rare endocrine diseases, today announced that the first patient has been ...

Breye Therapeutics announces successful completion of its Phase 1b trial with danegaptide in patients with diabetic retinopathy

PR Newswire COPENHAGEN, Denmark, June 24, 2025 COPENHAGEN, Denmark, June 24, 2025 /PRNewswire/ -- Breye Therapeutics ApS (Breye), a clinical-stage ophthalmology focused biopharmaceutical company developing oral therapeutics for the early ...

Lundbeck receives orphan drug designation in the US and EU for Lu AG13909 for the treatment of patients with congenital adrenal hyperplasia

PR Newswire VALBY, Denmark, June 24, 2025 VALBY, Denmark, June 24, 2025 /PRNewswire/ -- Lundbeck today announces that orphan drug designation has been granted to Lu AG13909 by the US Food and Drug Administration (FDA) on 12 May 2025 and the ...

Global Hygiene Expert Pittet: Hand Hygiene Saves 5 to 8 Million Lives Each Year

PR Newswire VIENNA and ZELL AM SEE, Austria, June 24, 2025 "Anyone visiting somebody in a hospital must disinfect their hands," says the long-standing advisor to the World Health Organization – Pittet to visit Austria on June 26, 2025 ...

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog at American Diabetes Association's 85th Scientific Sessions

PR Newswire SUZHOU, China, June 23, 2025 SUZHOU, China, June 23, 2025 /PRNewswire/ -- BrightGene Pharmaceutical Co., Ltd., an international, innovation-driven pharmaceutical company, presented data from two Phase 2 studies for BGM0504, its ...

Mifepristone Shown to Reduce A1C in Patients with Difficult-to-Control Type 2 Diabetes and Hypercortisolism

PR Newswire CHICAGO, June 23, 2025 Study Results Signal Paradigm Shift in Diabetes Care for Patients with Difficult-to-Control Type 2 Diabetes CHICAGO, June 23, 2025 /PRNewswire/ -- New findings from the CATALYST study show that the use ...

Medmovie Hx Heart App Launch Elevates Health Literacy and Empowers Shared Decision Making for Cardiovascular Care

PR Newswire LEXINGTON, Ky., June 23, 2025 Digital tool equips healthcare providers with trusted visual content to simplify complex heart information at the point of care LEXINGTON, Ky., June 23, 2025 /PRNewswire/ -- Medmovie, Inc., a ...

IHS Launches 'Help Hearing' Campaign at National Conference

PR Newswire FARMINGTON HILLS, Mich., June 23, 2025 FARMINGTON HILLS, Mich., June 23, 2025 /PRNewswire/ -- The International Hearing Society (IHS) kicked off its "Help Hearing" campaign while serving as one of 171 exhibitors at the Health ...

PRIORITIZE PROSTATE SCREENING--IT'S THE BEST DEFENSE AGAINST PROSTATE CANCER, SAYS PROCURE

PR Newswire SOMERSET, N.J., June 23, 2025 SOMERSET, N.J., June 23, 2025 /PRNewswire/ -- ProCure Proton Therapy Center reminds area residents about the critical importance to men of prostate-specific antigen (PSA) screenings for prostate ...

Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial

PR Newswire SAN JOSE, Calif., June 23, 2025 Fourth cohort dose is three million CAR positive cells; thirty times higher than the first cohort dose SAN JOSE, Calif., June 23, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the ...

Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU)

PR Newswire WARREN, N.J., June 23, 2025 – Broad label inclusive of all ages and disease severities – – Launch to be initiated in Germany – WARREN, N.J., June 23, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today ...

Leap Therapeutics Reports Updated Clinical Data from Sirexatamab Colorectal Cancer Study and Announces Exploration of Strategic Alternatives

PR Newswire CAMBRIDGE, Mass., June 23, 2025 Updated data from DeFianCe study continue to demonstrate statistically significant improvements in PFS among the DKK1-high, VEGF-naïve and liver metastasis subgroups Board of Directors has ...

Loma Linda University Health study shows vegetarian diets have reduced risk of medium-frequency cancers

PR Newswire LOMA LINDA, Calif., June 23, 2025 Researchers found that a vegetarian diet was associated with even greater risk reduction of stomach cancer, as high as 45%, as well as lymphomas by 25%. This is the first study with strong ...

Kanazawa University research: From hydration layers to nanoarchitectures: Water's pivotal role in peptide organization on 2D nanomaterials

PR Newswire KANAZAWA, Japan, June 23, 2025 KANAZAWA, Japan, June 23, 2025 /PRNewswire/ -- Researchers at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, report in Small, a weekly peer-reviewed scientific journal covering ...

Cell Study by SDU and PKU Researchers Reveals Novel Mechanism to Regulate Glucose Metabolism

PR Newswire JINAN, China, June 23, 2025 JINAN, China, June 23, 2025 /PRNewswire/ -- On May 29, 2025, Professor Sun Jinpeng's team and Professor Yu Xiao's team at Shandong University, collaborating with Professor Jiang Changtao from Peking ...

IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy of Neurology (EAN)

PR Newswire SHANGHAI and NANJING, China and SAN FRANCISCO, June 22, 2025 SHANGHAI and NANJING, China and SAN FRANCISCO, June 22, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, ...

EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds

PR Newswire HELSINKI, June 23, 2025 HELSINKI, June 23, 2025 /PRNewswire/ -- New research presented today at the European Academy of Neurology (EAN) Congress 2025 reveals that frequent nightmares are associated with significantly accelerated ...

Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes

PR Newswire CHICAGO, June 22, 2025 Oral formulation demonstrates comparable cardiovascular benefits to injectable GLP-1s CHICAGO, June 22, 2025 /PRNewswire/ -- A recent study found that oral semaglutide offers meaningful cardiovascular ...

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the ISTH 2025 Congress

PR Newswire PLAINSBORO, N.J., June 22, 2025 PLAINSBORO, N.J., June 22, 2025 /PRNewswire/ -- Novo Nordisk today presented results from the phase 3b FRONTIER5 trial showing that a direct switch to investigational Mim8 (denecimig) prophylaxis ...

Revolutionary Research by Dr. Takuma Hayashi Uncovers Molecular Origins of Deadly Uterine Cancer and Charts New Path for Treatment

PR Newswire MATSUMOTO, Japan, June 22, 2025 In a landmark advancement for women's cancer research, Dr. Takuma Hayashi and his team have made groundbreaking discoveries that could transform our understanding and treatment of uterine ...

Latest Press Releases

Premium Press Releases »

1000 Miglia 2025, Vesco-Salvinelli six times champions in a 1929 Alfa Romeo 6c 1750 Ss

Why Health Insurance Is a Must-Have in Today's World

Press Releases »

REZOLVE-AD Phase 2b Study of Rezpegaldesleukin Meets Primary and Key Secondary Endpoints in Patients with Moderate-to-Severe Atopic Dermatitis

School Children Jump to Raise $98K for American Heart Association

Colgate's Oral Health Movement - 4.5 Million Screened, Interesting Insights Uncovered, Drives Dental Visits Across India

Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis

Nuvalent Announces Positive Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC

Sterotherapeutics Announces First Patient Dosed in Phase 2 Clinical Trial Evaluating ST-002 for Cushing's Syndrome

Breye Therapeutics announces successful completion of its Phase 1b trial with danegaptide in patients with diabetic retinopathy

Lundbeck receives orphan drug designation in the US and EU for Lu AG13909 for the treatment of patients with congenital adrenal hyperplasia

Global Hygiene Expert Pittet: Hand Hygiene Saves 5 to 8 Million Lives Each Year

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog at American Diabetes Association's 85th Scientific Sessions

Mifepristone Shown to Reduce A1C in Patients with Difficult-to-Control Type 2 Diabetes and Hypercortisolism

Medmovie Hx Heart App Launch Elevates Health Literacy and Empowers Shared Decision Making for Cardiovascular Care

IHS Launches 'Help Hearing' Campaign at National Conference

PRIORITIZE PROSTATE SCREENING--IT'S THE BEST DEFENSE AGAINST PROSTATE CANCER, SAYS PROCURE

Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial

Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU)

Leap Therapeutics Reports Updated Clinical Data from Sirexatamab Colorectal Cancer Study and Announces Exploration of Strategic Alternatives

Loma Linda University Health study shows vegetarian diets have reduced risk of medium-frequency cancers

Kanazawa University research: From hydration layers to nanoarchitectures: Water's pivotal role in peptide organization on 2D nanomaterials

Cell Study by SDU and PKU Researchers Reveals Novel Mechanism to Regulate Glucose Metabolism

IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy of Neurology (EAN)

EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds

Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the ISTH 2025 Congress

Revolutionary Research by Dr. Takuma Hayashi Uncovers Molecular Origins of Deadly Uterine Cancer and Charts New Path for Treatment

Once-Weekly Insulin Efsitora Achieves Comparable A1C Reduction to Daily Insulin Therapy

Inhaled Insulin Shown as a Safe and Effective Replacement for Standard-of-Care in Children with Type 1 Diabetes

CagriSema Demonstrates Significant Weight Loss in Adults with Obesity

The American Diabetes Association Announces Winners of the Innovation Challenge to Transform Diabetes Care

Semaglutide Increases Walking Capacity in Patients with Peripheral Artery Disease and Type 2 Diabetes

Medindia Newsletters